METASTATIC SQUAMOUS CELL CARCINOMA

Clinical trials for METASTATIC SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Early trial tests new combo for Tough-to-Treat head & neck cancers

Disease control Completed

This early-stage study tested the safety of combining two immunotherapy drugs, IRX-2 and durvalumab, for patients with incurable head and neck cancer. The main goal was to find the highest dose patients could tolerate without severe side effects and to see if the treatment increa…

Matched conditions: METASTATIC SQUAMOUS CELL CARCINOMA

Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

METASTATIC SQUAMOUS CELL CARCINOMA

Get alerted when new METASTATIC SQUAMOUS CELL CARCINOMA trials appear

Early trial tests new combo for Tough-to-Treat head & neck cancers